Correlation Between Utah Medical and Akoya Biosciences

Can any of the company-specific risk be diversified away by investing in both Utah Medical and Akoya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and Akoya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Utah Medical Products and Akoya Biosciences, you can compare the effects of market volatilities on Utah Medical and Akoya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of Akoya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and Akoya Biosciences.

Diversification Opportunities for Utah Medical and Akoya Biosciences

0.46

Correlation Coefficient

Utah Medical  Akoya Biosciences

Very weak diversification

The 3 months correlation between Utah and Akoya is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and Akoya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akoya Biosciences and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with Akoya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akoya Biosciences has no effect on the direction of Utah Medical i.e., Utah Medical and Akoya Biosciences go up and down completely randomly.

Pair Corralation between Utah Medical and Akoya Biosciences

Given the investment horizon of 90 days Utah Medical Products is expected to under-perform the Akoya Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Utah Medical Products is 3.74 times less risky than Akoya Biosciences. The stock trades about -0.02 of its potential returns per unit of risk. The Akoya Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  219.00  in Akoya Biosciences on September 9, 2024 and sell it today you would lose (7.00) from holding Akoya Biosciences or give up 3.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Utah Medical Products  vs.  Akoya Biosciences

Utah Medical Products

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Akoya Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Utah Medical and Akoya Biosciences

The main advantage of trading using opposite Utah Medical and Akoya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, Akoya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akoya Biosciences will offset losses from the drop in Akoya Biosciences' long position.

The idea behind Utah Medical Products and Akoya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.